AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2009
Feb 26, 2009
30339_dirs_2009-02-26_d67ad7f4-e0b1-4130-b0bf-00b20f902f83.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-02-24
Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-02-24 | Common Stock | A | 1848.0963 | $32.09 | Acquired | 28852.0885 | Direct |
| 2009-02-24 | Common Stock | A | 984 | $32.09 | Acquired | 29836.0885 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-02-24 | Stock Option (Right to Buy) | $32.09 | A | 5500 | Acquired | 2019-02-24 | Common Stock (5500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 419.2193 | Indirect |
| Common Stock | 4497.7802 | Indirect |
Footnotes
F1: Bonus and Incentive shares granted on 2/24/09.
F2: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2006 that have vested for performance period V.
F3: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27